Triamcinolone + Nystatin Rx
Generic Name and Formulations:
Triamcinolone acetonide 0.1%, nystatin 100000units/g; crm; oint.
Various generic manufacturers
Indications for Triamcinolone + Nystatin:
Adults and Children:
Apply sparingly 2 times daily; max 25 days treatment.
Avoid prolonged use or on large areas. Use lowest effective dose (esp. in children). Do not occlude. Discontinue gradually in chronic use. Discontinue if superinfection or irritation occurs. Reevaluate if no improvement after 25 days. Pregnancy (Cat.C). Nursing mothers.
Steroid + polyene antifungal.
Local irritation, folliculitis, hypertrichosis, dermatitis, sensitization, HPA axis suppression (esp. in children), epidermal and dermal atrophy (esp. in thin-skinned or occluded areas).
Formerly known under the brand names Myco-triacet II, Mycolog II, Mytrex F.
Endocrinology Advisor Articles
- Higher BUN May Increase Risk for Incident Diabetes
- Efficacy of Novel GLP-1 Receptor Agonist Drug Device Examined
- Takeout Food May Increase Adverse Health Consequences in Children
- Nonhormonal Options Available for Menopause Symptom Relief
- Plasma Volume Changes Mediate Risk of CV Mortality With Empagliflozin
- New Consensus Recommendations on Use of Continuous Glucose Monitoring
- Does Genetic Susceptibility Lead to Late-Onset Type 1 Diabetes?
- Clinical Outcomes in T2D: Low-Carbohydrate vs Calorie-Restricted Diet
- New Continuous Glucose Monitoring System Now Available for Medicare Patients
- Text Message-Delivered Interventions Effective for Weight Management
- Effect of Intra-Articular Depot Betamethasone on Insulin Resistance in T2D
- Gastric Bypass vs Sleeve Gastrectomy Outcomes in Morbid Obesity
- Acute Kidney Injury Increases Risk for Postdischarge Hypoglycemia in Diabetes
- Novel Deep Learning System May Help Identify Diabetic Retinopathy
- Trends in CVD, Risk Factors, and Medications in Children With T1D